FDA panel unanimously recommends third Covid vaccine as J&J wins key vote in path to emergency use
Posted on AllSides February 26th, 2021
From The Center
A key Food and Drug Administration advisory panel on Friday unanimously backed Johnson & Johnson’s single-shot coronavirus vaccine for emergency use, a critical step paving the way to distribute a third preventative treatment in the U.S. next week.
The nonbinding decision, which was adopted 22-0, by the FDA’s Vaccines and Related Biological Products Advisory Committee comes as the Biden administration works to ramp up the supply of vaccine doses and get Americans vaccinated as quickly as possible. U.S. health officials are growing concerned about new, emerging variants of the virus,...
Some content from this outlet may be limited or behind a paywall.